MeSH D014564 - urogenital abnormalities
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D052776:Female urogenital diseases
0 Companies
0 Drugs
Success rate
D000091642:Urogenital diseases
0 Companies
0 Drugs
Success rate
D052801:Male urogenital diseases
0 Companies
0 Drugs
Success rate
D014564:
Urogenital abnormalities
0 Companies
0 Drugs
Success rate
D000069337:Fused kidney
0 Companies
0 Drugs
Success rate
D000075529:Solitary kidney
0 Companies
0 Drugs
Success rate
D001746:Bladder exstrophy
0 Companies
0 Drugs
Success rate
D004842:Epispadias
0 Companies
0 Drugs
Success rate
D007021:Hypospadias
0 Companies
0 Drugs
Success rate
D009394:Hereditary nephritis
0 Companies
0 Drugs
Success rate
D012734:Disorders of sex development
0 Companies
0 Drugs
Success rate
D014548:Urinary fistula
0 Companies
0 Drugs
Success rate
D021782:Multicystic dysplastic kidney
0 Companies
0 Drugs
Success rate
D058497:Fraser syndrome
0 Companies
0 Drugs
Success rate
D064749:Retrocaval ureter
0 Companies
0 Drugs
Success rate
D000093662:Uterine duplication anomalies
0 Companies
0 Drugs
Success rate
D003456:Cryptorchidism
D058536:Pyelectasis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/8
Phase 2
0%0/0
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use